BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 26388542)

  • 1. Progressive supranuclear palsy and Parkinson's disease overlap: A clinicopathological case report.
    Araki K; Sumikura H; Matsudaira T; Sugiura A; Takao M; Murayama S; Obi T
    Neuropathology; 2016 Apr; 36(2):187-91. PubMed ID: 26388542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Co-occurrence of Parkinson's disease with progressive supranuclear palsy.
    Judkins AR; Forman MS; Uryu K; Hinkle DA; Asbury AK; Lee VM; Trojanowski JQ
    Acta Neuropathol; 2002 May; 103(5):526-30. PubMed ID: 11935271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brain alpha-synuclein accumulation in multiple system atrophy, Parkinson's disease and progressive supranuclear palsy: a comparative investigation.
    Tong J; Wong H; Guttman M; Ang LC; Forno LS; Shimadzu M; Rajput AH; Muenter MD; Kish SJ; Hornykiewicz O; Furukawa Y
    Brain; 2010 Jan; 133(Pt 1):172-88. PubMed ID: 19903734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Different tau pathology pattern in two clinical phenotypes of progressive supranuclear palsy.
    Jellinger KA
    Neurodegener Dis; 2008; 5(6):339-46. PubMed ID: 18349518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of degeneration in motor thalamus and cortex between progressive supranuclear palsy and Parkinson's disease.
    Halliday GM; Macdonald V; Henderson JM
    Brain; 2005 Oct; 128(Pt 10):2272-80. PubMed ID: 16014651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Co-existence of Parkinson's disease and progressive supranuclear palsy: case report and a review of the literature.
    Abhinav K; Marsh L; Crain B; Reich SG; Biglan K
    Neurol Sci; 2011 Feb; 32(1):159-63. PubMed ID: 20737180
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A 65-year-old man with Parkinsonism, gaze palsy, and dementia].
    Mizuno Y; Yokochi F; Ohta S; Mori H; Takubo H
    No To Shinkei; 1996 Apr; 48(4):381-93. PubMed ID: 8679336
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of thalamic intralaminar nuclei in progressive supranuclear palsy and Parkinson's disease: clinical and therapeutic implications.
    Henderson JM; Carpenter K; Cartwright H; Halliday GM
    Brain; 2000 Jul; 123 ( Pt 7)():1410-21. PubMed ID: 10869053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A 65-year-old man with rigid-bradykinetic parkinsonism, vertical gaze palsy, difficulty of eye-lid opening, and marked pseudo-bulbar palsy].
    Noda K; Kobayashi T; Matsuoka S; Takanashi M; Kanazawa A; Mizuno Y
    No To Shinkei; 2005 Jan; 57(1):73-86. PubMed ID: 15782604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lewy bodies in progressive supranuclear palsy represent an independent disease process.
    Uchikado H; DelleDonne A; Ahmed Z; Dickson DW
    J Neuropathol Exp Neurol; 2006 Apr; 65(4):387-95. PubMed ID: 16691119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Parkinson's disease and parkinsonism: neuropathology.
    Dickson DW
    Cold Spring Harb Perspect Med; 2012 Aug; 2(8):. PubMed ID: 22908195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patterns of brain atrophy in Parkinson's disease, progressive supranuclear palsy and multiple system atrophy.
    Messina D; Cerasa A; Condino F; Arabia G; Novellino F; Nicoletti G; Salsone M; Morelli M; Lanza PL; Quattrone A
    Parkinsonism Relat Disord; 2011 Mar; 17(3):172-6. PubMed ID: 21236720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Histologic Study of the Circadian System in Parkinson Disease, Multiple System Atrophy, and Progressive Supranuclear Palsy.
    De Pablo-Fernández E; Courtney R; Warner TT; Holton JL
    JAMA Neurol; 2018 Aug; 75(8):1008-1012. PubMed ID: 29710120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lewy bodies in progressive supranuclear palsy.
    Mori H; Oda M; Komori T; Arai N; Takanashi M; Mizutani T; Hirai S; Mizuno Y
    Acta Neuropathol; 2002 Sep; 104(3):273-8. PubMed ID: 12172913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progressive supranuclear palsy affects both the substantia nigra pars compacta and reticulata.
    Hardman CD; Halliday GM; McRitchie DA; Cartwright HR; Morris JG
    Exp Neurol; 1997 Mar; 144(1):183-92. PubMed ID: 9126169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Familial progressive supranuclear palsy.
    Gazeley S; Maguire JA
    Clin Neuropathol; 1996; 15(4):215-20. PubMed ID: 8836606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autonomic dysfunction in patients with progressive supranuclear palsy.
    Schmidt C; Herting B; Prieur S; Junghanns S; Schweitzer K; Reichmann H; Berg D; Ziemssen T
    Mov Disord; 2008 Oct; 23(14):2083-9. PubMed ID: 18792126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemical study of a case with progressive supranuclear palsy without ophthalmoplegia.
    Kida E; Barcikowska M; Niemczewska M
    Acta Neuropathol; 1992; 83(3):328-32. PubMed ID: 1557959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progressive supranuclear palsy presenting with primary progressive aphasia--clinicopathological report of an autopsy case.
    Mochizuki A; Ueda Y; Komatsuzaki Y; Tsuchiya K; Arai T; Shoji S
    Acta Neuropathol; 2003 Jun; 105(6):610-4. PubMed ID: 12669238
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lewy body-related alpha-synucleinopathy in the aged human brain.
    Jellinger KA
    J Neural Transm (Vienna); 2004 Oct; 111(10-11):1219-35. PubMed ID: 15480835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.